Crystal structure prediction methods have been used to explore the potential energy landscape for crystals of a melatonin agonist (MA). All known experimental polymorphs were found in the search for crystal packing alternatives with a single molecule in the asymmetric unit, and the predicted order of stability agrees with experiment. The crystal structure corresponding to the global minimum has not been observed experimentally, but analysis of the crystal structures of similar molecules in the Cambridge Structural Database (CSD) indicates that the packing motif present in the predicted structure is also found in nature. To date it has not been experimentally possible to crystallize the most stable polymorph of the biologically active <i>R</...
Loratadine, an over-the-counter antihistamine medication, has two known monotropically related polym...
The packing of molecules in solids greatly affects the properties of the bulk materials. This is par...
In the pharmaceutical industry, the control of a new drug’s crystal form is key to optimise its form...
Crystal structure prediction methods have been used to explore the potential energy landscape for cr...
Computational methods used for predicting the crystal structures of organic compounds are mature eno...
The ab initio prediction of molecular crystal structures is a scientific challenge. Reliability of f...
AbstractOrganic molecules can crystallize in multiple structures or polymorphs, yielding crystals wi...
The knowledge of the packing behaviour of small organic compounds in crystal lattices is of great im...
peer reviewedReliable prediction of the polymorphic energy landscape of a molecular crystal would yi...
Organic molecules, such as pharmaceuticals, agro-chemicals and pigments, frequently form several cry...
To evaluate how the calculation of a crystal energy landscape can be used in the solid-form screenin...
The ability to predict the properties of a crystal structure before any empirical analysis or labora...
A computational exploration of the low energy crystal structures of the pharmaceutical molecule phen...
No AbstractPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/64302/1/8657_ftp.pd
Polymorphs are different crystalline modifications of the same chemical substance. When different co...
Loratadine, an over-the-counter antihistamine medication, has two known monotropically related polym...
The packing of molecules in solids greatly affects the properties of the bulk materials. This is par...
In the pharmaceutical industry, the control of a new drug’s crystal form is key to optimise its form...
Crystal structure prediction methods have been used to explore the potential energy landscape for cr...
Computational methods used for predicting the crystal structures of organic compounds are mature eno...
The ab initio prediction of molecular crystal structures is a scientific challenge. Reliability of f...
AbstractOrganic molecules can crystallize in multiple structures or polymorphs, yielding crystals wi...
The knowledge of the packing behaviour of small organic compounds in crystal lattices is of great im...
peer reviewedReliable prediction of the polymorphic energy landscape of a molecular crystal would yi...
Organic molecules, such as pharmaceuticals, agro-chemicals and pigments, frequently form several cry...
To evaluate how the calculation of a crystal energy landscape can be used in the solid-form screenin...
The ability to predict the properties of a crystal structure before any empirical analysis or labora...
A computational exploration of the low energy crystal structures of the pharmaceutical molecule phen...
No AbstractPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/64302/1/8657_ftp.pd
Polymorphs are different crystalline modifications of the same chemical substance. When different co...
Loratadine, an over-the-counter antihistamine medication, has two known monotropically related polym...
The packing of molecules in solids greatly affects the properties of the bulk materials. This is par...
In the pharmaceutical industry, the control of a new drug’s crystal form is key to optimise its form...